Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Mistakes happen, but you can recover. This starter guide shows how to assess the damage, prioritize essential expenses, and rebuild your budget step by step.
20,430 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Bitcoin trades in a tight corridor near the mid-$60k range, defying a clear bullish breakout as ETF flows wane and Fe...
Micah Lasher won a crowded Democratic primary in Manhattan, delivering a setback to the Kennedy legacy. The race also...
Private credit making investors nervous highlights how market risk, defaults, and liquidity affect BDCs. Yet Main Str...
New CoinGecko data reveals most tokens on Pump.fun fail to survive the first trading day, underscoring risk in the me...
Carnival beat on the bottom line and top line, but the stock sank on the day. Analysts point to a price prediction: c...
Marvell Technology has surged in 2026 as AI infrastructure demand accelerates. Here is a timely look at the case for ...
A high-stakes cash bid from Merck KGaA sent Bio-Techne stock higher and sparked a flurry of trading. Here’s what inve...
Medicare Part B premiums and income-based IRMAA surcharges are reshaping retirement budgets in 2026. The typical reti...
A bitcoin miners ETF posted a dramatic weekly surge, underscoring how mining infrastructure can deliver cash flows ev...
A major milestone sits on the horizon: Securitize, with BlackRock backing, is preparing to trade as a tokenized secur...
Bitcoin’s price finally entered a defined buy zone this week, signaling a potential shift in sentiment as traders wei...